Literature DB >> 8167469

Refolding and characterization of human recombinant heparin-binding neurite-promoting factor.

A P Seddon1, J D Hulmes, M M Decker, I Kovesdi, J L Fairhurst, J Backer, M Dougher-Vermazen, P Böhlen.   

Abstract

Heparin-binding neurite-promoting factor (HBNF) is a highly basic, cysteine-rich 136-residue protein, and a member of a new class of heparin-binding proteins. It exhibits a neurite-outgrowth promoting activity and its expression is both temporally and spacially regulated during fetal and postnatal development. A high interspecies sequence conservation suggests important, presently unknown, biological functions. HBNF is structurally and most likely functionally related to the product of a developmentally regulated gene, MK (midkine). To elucidate biological roles of these proteins, recombinant forms of the proteins were produced. Expression of human recombinant HBNF and MK in Escherichia coli lead to the formation of insoluble aggregated protein that accounted for about 25% of the total cellular protein. Homogeneous, monomeric forms of each protein were recovered from inclusion bodies by reduction with dithiothreitol and solubilization in 8 M urea. Refolding of the reduced and denatured protein occurred upon dialysis at pH 7.4. Human recombinant (hr) HBNF and hrMK prepared in this manner were further purified by heparin affinity chromatography. Chromatographic evidence demonstrates that refolding and concomitant disulfide bond formation in hrHBNF proceeds in high yield with minimal formation of stable nonnative disulfides. Studies on the redox status of the 10 cysteine residues of bovine brain HBNF and the refolded recombinant protein indicate that all cysteines are engaged in disulfide bond formation. The disulfide arrangements for the recombinant protein were found to be identical to those in the native protein isolated from bovine brain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167469     DOI: 10.1006/prep.1994.1002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation.

Authors:  Brigitte Blondet; Gilles Carpentier; Arnaud Ferry; José Courty
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

3.  Expression and purification of bioactive high-purity human midkine in Escherichia coli.

Authors:  Zhong-hui Zhang; Li-juan Du; Di Xiang; Shun-ying Zhu; Ming-yuan Wu; Hui-li Lu; Yan Yu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

4.  Pleiotrophin is a neurotrophic factor for spinal motor neurons.

Authors:  Ruifa Mi; Weiran Chen; Ahmet Höke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.